Kahramanmaras Sutcu Imam University
Kahramanmaraş, Onikişubat, 46050, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT06181903
Emotional freedom technique will be applied to women with risky pregnancy. Emotional freedom technique group and control groups each consisted of 60 pregnant women.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Kahramanmaraş, Onikişubat, 46050, Turkey (Türkiye)
Location status: Recruiting
Objective In this experimental study, it was aimed to examine the effect of emotional freedom technique applied to women with risky pregnancy on mental well-being and stress levels.
Materials and Methods: This randomized controlled study will be conducted between February 2024 and August 2024 in Kahramanmaraş Necip Fazıl City Hospital Obstetrics and Gynecology Annex Building Obstetrics Outpatient Clinics with a total of 120 risk pregnant women (60 EFT, 60 control). EFT will be applied in the study. Women in the EFT group will receive EFT four times at one-week intervals. Pretest data will be obtained by filling out the Personal Information Form, Warwick-Edinburgh Mental Well-Being Scale (WEMWB), Prenatal Distress Scale - Revised Version before the Emotional Freedom Technique application. After the interventions, post-test data will be obtained by completing the Warwick-Edinburgh Mental Well-Being Scale (WEMWB), Prenatal Distress Scale - Revised Version. In addition, the Subjective Units of Experience (SUE) scale will be administered before and after each EFT intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Control group
Other names: No Intervention
Time frame: The Warwick-Edinburgh Mental Well-Being Scale will be administered to two groups of pregnant women on day one (first interview)
The scale is a 14-item, self-report style scale. The scale consists of positive items including hedonic and eudaimonic dimensions of mental well-being, optimism, feeling useful, relaxation, interest in other people, being energetic and lively, coping with problems, clear thinking, feeling good, feeling close to other people, self-confidence, decision-making, love, interest in new things and being cheerful. The scale covers psychological well-being and subjective well-being and deals with the positive mental health of individuals. The scale is a five-point Likert scale with a minimum score of 14 and a maximum score of 70. Scoring of the scale is as follows: strongly disagree (1), disagree (2), somewhat agree (3), agree (4), strongly agree (5). All items of the scale are positive. High scores on the scale indicate high mental well-being.
Time frame: The Warwick-Edinburgh Mental Well-Being Scale will be administered to three groups of menopausal women at the last interview (after the 4th intervention at one week interval).
The scale is a 14-item, self-report style scale. The scale consists of positive items including hedonic and eudaimonic dimensions of mental well-being, optimism, feeling useful, relaxation, interest in other people, being energetic and lively, coping with problems, clear thinking, feeling good, feeling close to other people, self-confidence, decision-making, love, interest in new things and being cheerful. The scale covers psychological well-being and subjective well-being and deals with the positive mental health of individuals. The scale is a five-point Likert scale with a minimum score of 14 and a maximum score of 70. Scoring of the scale is as follows: strongly disagree (1), disagree (2), somewhat agree (3), agree (4), strongly agree (5). All items of the scale are positive. High scores on the scale indicate high mental well-being.
Time frame: The Prenatal Distress Scale - Revised Version will be administered to two groups of pregnant women on day one (first interview)
The scale determines pregnant women's social relationships, their physical and emotional symptoms during pregnancy, and their level of anxiety about themselves and their babies. The scale items have options ranging from "Not at all" (0), "A little" (1) and "Very much" (2), and the total score is obtained by summing the scores of the answers given to the scale items. A minimum score of 0 and a maximum score of 34 points are obtained from the scale. An increase in the total score obtained from the scale indicates an increase in the level of prenatal distress perceived by pregnant women.
Time frame: The Prenatal Distress Scale - Revised Version will be administered to three groups of menopausal women at the last interview (after the 4th intervention at one week interval).
The scale determines pregnant women's social relationships, their physical and emotional symptoms during pregnancy, and their level of anxiety about themselves and their babies. The scale items have options ranging from "Not at all" (0), "A little" (1) and "Very much" (2), and the total score is obtained by summing the scores of the answers given to the scale items. A minimum score of 0 and a maximum score of 34 points are obtained from the scale. An increase in the total score obtained from the scale indicates an increase in the level of prenatal distress perceived by pregnant women.
Time frame: The Subjective Units of Experience (SUE) scale will be administered to two groups of pregnant women on day one (first interview)
Subjective Units of Experience (SUE) will be applied to determine the anxiety level of pregnant women. The SUE is used to determine the intensity of one's emotions at the beginning and end of the therapy. The scale is scored between -10 and +10, with negative numbers indicating negative/unpleasant experiences and positive numbers indicating positive/pleasant experiences.
Time frame: One hour after the first interview, all pregnant women in all two groups will be administered the SUE (second measure)
Subjective Units of Experience (SUE) will be applied to determine the anxiety level of pregnant women. The SUE is used to determine the intensity of one's emotions at the beginning and end of the therapy. The scale is scored between -10 and +10, with negative numbers indicating negative/unpleasant experiences and positive numbers indicating positive/pleasant experiences.
Time frame: Seven days after the first interview, all pregnant women in all two groups will be administered the SUE (third measurement)
Subjective Units of Experience (SUE) will be applied to determine the anxiety level of pregnant women. The SUE is used to determine the intensity of one's emotions at the beginning and end of the therapy. The scale is scored between -10 and +10, with negative numbers indicating negative/unpleasant experiences and positive numbers indicating positive/pleasant experiences.
Time frame: One hour after the third measurement, all pregnant women in all two groups will be administered the SUE (fourth measurement)
Subjective Units of Experience (SUE) will be applied to determine the anxiety level of pregnant women. The SUE is used to determine the intensity of one's emotions at the beginning and end of the therapy. The scale is scored between -10 and +10, with negative numbers indicating negative/unpleasant experiences and positive numbers indicating positive/pleasant experiences.
Time frame: Seven days after the fourth measurement, all pregnant women in all two groups will be administered the SUE (fifth measurement)
Subjective Units of Experience (SUE) will be applied to determine the anxiety level of pregnant women. The SUE is used to determine the intensity of one's emotions at the beginning and end of the therapy. The scale is scored between -10 and +10, with negative numbers indicating negative/unpleasant experiences and positive numbers indicating positive/pleasant experiences.
Time frame: : One hour after the fifth measurement, all pregnant women in all two groups will be administered the SUE (sixth measurement)
Subjective Units of Experience (SUE) will be applied to determine the anxiety level of pregnant women. The SUE is used to determine the intensity of one's emotions at the beginning and end of the therapy. The scale is scored between -10 and +10, with negative numbers indicating negative/unpleasant experiences and positive numbers indicating positive/pleasant experiences.
Time frame: Seven days after the sixth measurement, all pregnant women in all two groups will undergo the SUE (seventh measurement).
Subjective Units of Experience (SUE) will be applied to determine the anxiety level of pregnant women. The SUE is used to determine the intensity of one's emotions at the beginning and end of the therapy. The scale is scored between -10 and +10, with negative numbers indicating negative/unpleasant experiences and positive numbers indicating positive/pleasant experiences.
Time frame: One hour after the seventh measurement, all pregnant women in all two groups will be administered the SUE (eighth measurement)
Subjective Units of Experience (SUE) will be applied to determine the anxiety level of pregnant women. The SUE is used to determine the intensity of one's emotions at the beginning and end of the therapy. The scale is scored between -10 and +10, with negative numbers indicating negative/unpleasant experiences and positive numbers indicating positive/pleasant experiences.
Contact information is provided by the study sponsor or research team.
Esra GÜNEY, PhD
CONTACT
Esra KARATAŞ OKYAY, PhD
CONTACT
Kahramanmaras Sutcu Imam University
Other
The Effect of Emotional Freedom Technique Applied to Women With Risky Pregnancy on Mental Well-Being and Stress Level
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07559955
Behavior, Behavioral Symptoms
New York, United States
View Trial DetailsNCT07740291
Addiction, Behavior
Lubbock, Texas, United States
View Trial DetailsNCT07494929
Behavior, Mental Health
Heidelberg, Germany
View Trial DetailsNCT07737353
Anxiety Disorders, Behavior
Giresun, Turkey (Türkiye)
View Trial Details